We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

Facts & Stats Learn more about osteoporosis and related fractures Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which can lead to increased risk […]

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

AFTER THE FRACTURE If you have recently broken a bone, you have come to the right place! The information that follows will help you to understand the pain that you […]

On May 25, 2012 Sun Life Financial announced a donation of $ 103,232 to the Fracture Navigator Program, led by Dr. Diane Theriault at the Dartmouth General Hospital in Nova […]

Osteoporosis can have a significant impact on our physical and emotional well-being including how broken bones and the diagnosis of osteoporosis can affect our sexuality and intimacy. Sexuality can be […]

If you are on medication for osteoporosis, are you ever tempted to stop taking it? If your answer is yes, you are not alone. Studies indicate that especially for those […]

On behalf of Osteoporosis Canada’s Scientific Advisory Consultants and Osteoporosis Canada, we would like to announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. […]

Aliya Khan, Heather Frame,  Claudia Gagnon,  Rowena Ridout , Lianne Tile,  Wendy Ward, Sandra Kim Recently Duerksen and colleagues published on fracture risk assessment in celiac disease – a registry-based […]